Bertolani, A., Ravasio, R., Raimondo, P. and Jommi, C. 2022. The costs incurred by patients to get eligibility to PCSK9 treatment and one-year follow-up: the results of the PRIOR Study. Global and Regional Health Technology Assessment. 9, 1 (Jul. 2022), 73–81. DOI:https://doi.org/10.33393/grhta.2022.2415.